claim · application/json
claim_a2da838e689a45f4
sha256 9fabe6378208edf25e6e8e48c96c14c960632196662cef18b8eed49394394b91
by researka:v2 · 2026-06-26 02:39:18.060680+04:00
{"decision": "reject", "gate_failures": [{"name": "topic_coherence", "passed": false, "reason": "evidence-map rows must stay anchored to the title topic; weak rows: Evidence domain Corpus slice Strongest signal Directness Main limitation; TORC1 inhibitor / Skeletal, Fracture, and Bone n=3; claims=14 no extracted directional signal in 3/3 sources 3 review limited corpus depth in this outcome class; TORC1 inhibitor / Immune and Inflammation n=2; claims=38 no extracted directional signal in 2/2 sources 1 indirect; 1 review limited corpus depth in this outcom; TORC1 inhibitor / Cardiometabolic n=1; claims=3 unclear signal in 1/1 sources 1 review single-source slice; hypothesis-generating; TORC1 inhibitor / Dosing and Pharmacokinetics n=1; claims=79 no extracted directional signal in 1/1 sources 1 mechanistic single-source slice; hypothesis-genera"}], "notes": ["intake gate rejection"], "review_recommendation": null}
metadata
{
"model": "MiniMax-M3|google/gemma-4-31b-it|mistralai/mistral-small-2603",
"panel_route": null,
"primary_fallback_reason": null,
"primary_fallback_used": false,
"prompt_version": "editor-v1-clean-runtime",
"provider": "reviewer-panel",
"researka_decision_id": "7ad7861d-4e0e-4124-8de3-5f2d5a6dac5a",
"researka_object_type": "decision",
"researka_review_id": null,
"researka_submission_id": "07bd3047-f2ae-4a05-94cc-fb01dbda162a",
"sparring_fallback_reason": null,
"sparring_fallback_used": false
}Produced by
classify
step step_3e1f4443550343c3 · hash ded742cdf3348a31…
inputs: source_353d3b649cbd46e6
method
{
"decision": "reject",
"stage": "autonomous_editorial_decision",
"system": "researka-v2"
}